Fallopian Tube Cancer Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
14 nov. 2022 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Fallopian Tube Cancer Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight Abnormal...
Genelux Corporation Initiates a Pivotal Phase 3 Trial, Evaluating Olvi-Vec for the treatment of Platinum-Resistant/Refractory Ovarian Cancer
21 sept. 2022 08h06 HE
|
Genelux Corporation
The Company’s first Phase 3 trial, OnPrime (GOG-3076), will evaluate Olvi-Vec, a modified vaccinia virus, as immunochemotherapy Trial will be conducted as a collaboration between Genelux and The...
Asia Pacific Cancer Gene Therapy Market Report 2022: Featuring Key Players Novartis, GlaxoSmithKline, Amgen, Bristol Myers Squibb, Gilead Sciences,. Adaptimmune, Genelux & Sarepta Therapeutics,
04 août 2022 04h53 HE
|
Research and Markets
Dublin, Aug. 04, 2022 (GLOBE NEWSWIRE) -- The "Asia Pacific Cancer Gene Therapy Market Size, Share & Industry Trends Analysis Report By Therapy (Gene Induced Immunotherapy, Oncolytic...
Global Viral Vector Manufacturing Market to Reach $1.2 Billion by 2026
23 juin 2022 06h23 HE
|
ReportLinker
New York, June 23, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Viral Vector Manufacturing Industry" - https://www.reportlinker.com/p05799925/?utm_source=GNW...
Global Cancer Gene Therapy Market Report to 2028 - Size, Share & Industry Trends Analysis Report
17 juin 2022 06h43 HE
|
Research and Markets
Dublin, June 17, 2022 (GLOBE NEWSWIRE) -- The "Global Cancer Gene Therapy Market Size, Share & Industry Trends Analysis Report By Therapy (Gene Induced Immunotherapy, Oncolytic Virotherapy, and...
Peritoneal Cancer Pipeline Insights | Clinical Trial Research Evaluation Report
13 juin 2022 12h00 HE
|
DelveInsight Business Research LLP
New York, USA, June 13, 2022 (GLOBE NEWSWIRE) -- Peritoneal Cancer Pipeline Insights | Clinical Trial Research Evaluation Report The rising prevalence of Peritoneal Cancer has drawn the...
Oncolytic Virus Cancer Therapy Pipeline Shows Rapid Progress in Clinical Trials, Assesses DelveInsight
18 mai 2022 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, May 18, 2022 (GLOBE NEWSWIRE) -- Oncolytic Virus Cancer Therapy Pipeline Shows Rapid Progress in Clinical Trials, Assesses DelveInsight Oncolytic Virus Cancer Therapy Pipeline...
Global Oncolytic Virus Therapies Market: Focus on Commercialized Therapies, Pipeline Therapies, Type of Virus, Application, Region, and Competitive Landscape - Analysis and Forecast, 2020-2030
15 avr. 2021 06h49 HE
|
ReportLinker
New York, April 15, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Oncolytic Virus Therapies Market: Focus on Commercialized Therapies, Pipeline Therapies,...
Global Rare Disease Market is estimated to be US$ 547.5 billion by 2030 with a CAGR of 13.1% during the forecast period - by PMI
24 févr. 2021 10h35 HE
|
PMI
Covina CA, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Global Rare Disease Market accounted for US$ 161.4 billion in 2020 and is estimated to be US$ 547.5 billion by 2030 and is anticipated to register a CAGR...
Global Oncolytic Virus Therapy Market 2026 Companies Clinical Trials Insight
02 nov. 2020 03h37 HE
|
KuicK Research
DELHI, India, Nov. 02, 2020 (GLOBE NEWSWIRE) -- "Global Oncolytic Virus Immunotherapy Market, Dosage, Price & Clinical Trials Outlook 2026" Report Highlights: Global Oncolytic Virus...